Structural Biology in Cancer Research

Structural Biology in Cancer Research

The major part of research is being carried out in the area of cancer. The main aim is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modeling mainly aims at drug designing. Eventually, many researchers in Structural biology carry out cancer research to extend the exploitation of molecular understanding of biomolecules in the advancement of novel cancer therapies. Cancer immunotherapy is also used which is defined as the response of immune system to reject cancer. Immunotherapies can be a better way of treating cancer. The malignant tumor cells are attacked by stimulating the immune system as these cells are responsible to exploit the fact that cancer cells often have molecules on their surface that can be detected by the tumor-associated antigens (TAAs).

  • Antibody Therapy

  • Cellular Immunotherapy

  • Cytokine Therapy

  • Combinational Immunotherapy

    Related Conference of Structural Biology in Cancer Research

    September 24-26, 2018

    14th International Conference on Structural Biology

    Berlin, Germany
    October 03-04, 2018 |

    4th International Conference on Biochemistry & Metabolomics

    Los Angeles, California, USA
    October 11-12, 2018

    13th International Conference on Metabolomics and Systems Biology

    Hilton Zurich Airport Hohenbuehlstrasse 10, 8152, Opfikon, Switzerland
    October 18-19, 2018

    10th International Congress on Structural Biology

    Helsinki, Finland
    November 19-20, 2018

    15th World Congress on

    Structural Biology

    Paris, France
    February 28-March 01, 2019

    5th International Conference on Enzymology and Protein Chemistry

    Berlin, Germany
    July 31-August 01, 2019

    6th International Conference on Glycobiology & Glycoproteomics

    Chicago, Illinois, USA

    Structural Biology in Cancer Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in